5.35
+8.74%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About GridAI Technologies
From its filings with the US Securities and Exchange Commission
GridAI Technologies is based in Boca Raton, Florida and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker GRDX. The SEC classifies its business as electric & other services combined. In the fiscal year to 31 December 2025, it reported revenue of $36,251 and a net loss of $6.4m. At that date it held total assets of $48.6m.
On September 30, 2025, the Company completed a share exchange transaction pursuant to which it acquired 100% of the outstanding equity interests of Grid AI Corp., a Nevada corporation. At the time of the acquisition, Grid AI Corp. owned 75% of the issued and outstanding equity interests of AMPX UK Holdings, a Cayman Islands company, which holds the operating subsidiary AMPX Limited. Following the transaction, Grid AI Corp. and its subsidiaries, including AMPX, became consolidated subsidiaries of the Company.
Grid AI Corp. develops software and services designed to accelerate power availability and optimize energy infrastructure for artificial intelligence (AI) data centers and other large energy users. Grid Ai Corp. is currently in the development stage of an AI data center platform. This platform aims to use and optimize distributed energy resources, including battery energy storage systems, on-site generation, and grid interconnections. Currently, there is no revenue generated from this AI data center platform. Grid Ai Corp.’s commercial pipeline has recently been re-established and is continuing to develop through consulting-led engagements and targeted business development initiatives.
Quoted from its 10-K, filed 1 May 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 11 Oct 2016
- Employees
- 10
- Website
- firstwavebio.com ↗
- Head office
- 433 PLAZA REAL, BOCA RATON, FL
- Incorporated in
- DE
- Classification
- Electric & Other Services Combined
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Jason SawyerInterim Chief Executive Officer, Director, since 2025
- Ms. Anna SkowronChief Financial Officer
- Mr. Edward BorkowskiLead Independent Director$172,498
- Mr. Geordan PursgloveDirector
- Mr. Eric CorbettIndependent Director
- Dr. Jack SyageIndependent Director, since 2024
- Mr. Manpreet UppalIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- First Wave BioPharma Inc focuses on clinical-stage biopharmaceutical development in gastrointestinal diseases.
- The company has two Phase 2 clinical programs for niclosamide formulations targeting GI infections and ulcerative proctitis.
- GridAI Technologies Corp employs 10 full-time employees with a focus on targeted non-systemic therapies.
Weaknesses
- First Wave BioPharma Inc has only 10 employees which limits its operational capacity.
- The company's clinical-stage development requires significant capital investment for ongoing research.
- GridAI Technologies Corp's IPO was in 2016, indicating limited market presence.
Opportunities
- The growing demand for targeted GI therapies presents a significant market opportunity.
- First Wave BioPharma Inc's adrulipase program targets cystic fibrosis and chronic pancreatitis patients.
- The company's FW-COV program addresses GI infections from SARS-CoV-2, aligning with pandemic needs.
Threats
- The biotechnology industry faces high regulatory hurdles for clinical-stage drug development.
- First Wave BioPharma Inc's limited employee count may hinder rapid response to market changes.
- GridAI Technologies Corp's small size could lead to financial instability in competitive markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.